CH614948A5 - - Google Patents

Info

Publication number
CH614948A5
CH614948A5 CH785775A CH785775A CH614948A5 CH 614948 A5 CH614948 A5 CH 614948A5 CH 785775 A CH785775 A CH 785775A CH 785775 A CH785775 A CH 785775A CH 614948 A5 CH614948 A5 CH 614948A5
Authority
CH
Switzerland
Application number
CH785775A
Inventor
Stanford S Pelosi Jr
Ronald E White
Ralph L White Jr
George C Wright
Chia-Nien Yu
Original Assignee
Morton Norwich Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morton Norwich Products Inc filed Critical Morton Norwich Products Inc
Publication of CH614948A5 publication Critical patent/CH614948A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
CH785775A 1974-06-17 1975-06-17 CH614948A5 (US08124630-20120228-C00102.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US479830A US3906010A (en) 1974-06-17 1974-06-17 Series of 5-aryl-2-furamidines

Publications (1)

Publication Number Publication Date
CH614948A5 true CH614948A5 (US08124630-20120228-C00102.png) 1979-12-28

Family

ID=23905619

Family Applications (1)

Application Number Title Priority Date Filing Date
CH785775A CH614948A5 (US08124630-20120228-C00102.png) 1974-06-17 1975-06-17

Country Status (12)

Country Link
US (1) US3906010A (US08124630-20120228-C00102.png)
JP (1) JPS5111758A (US08124630-20120228-C00102.png)
BE (1) BE830345A (US08124630-20120228-C00102.png)
CA (1) CA1019328A (US08124630-20120228-C00102.png)
CH (1) CH614948A5 (US08124630-20120228-C00102.png)
DE (1) DE2526799A1 (US08124630-20120228-C00102.png)
ES (1) ES438652A1 (US08124630-20120228-C00102.png)
FR (1) FR2279393A1 (US08124630-20120228-C00102.png)
GB (1) GB1443503A (US08124630-20120228-C00102.png)
NL (1) NL7502598A (US08124630-20120228-C00102.png)
SE (1) SE418292B (US08124630-20120228-C00102.png)
ZA (1) ZA75434B (US08124630-20120228-C00102.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217286A (en) * 1977-01-25 1980-08-12 Morton-Norwich Products, Inc. 5-Phenyl-2-furancarboximidamides
US4066670A (en) * 1977-01-25 1978-01-03 Morton-Norwich Products, Inc. N-dimethylaminopropyl-5-(2-nitrophenyl)-2-furancarboximidamide dihydrochloride monohydrate
US4159274A (en) * 1978-03-15 1979-06-26 Morton-Norwich Products, Inc. 7-Nitro-2-benzofurancarboximidamide hydrochloride
US4339386A (en) * 1981-08-05 1982-07-13 Morton-Norwich Products, Inc. 5-[(3,4-Dimethoxyphenyl)or(4-chlorophenyl)]-2-furancarboxaldehyde-O-[(methylamino)carbonyl]oxime
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
TW224974B (US08124630-20120228-C00102.png) * 1991-07-02 1994-06-11 Hoffmann La Roche
NZ506773A (en) 1998-04-29 2004-03-26 Procter & Gamble Process for making 1, 3-disubstituted-4-oxocyclic ureas
BR9910074A (pt) 1998-04-29 2000-12-26 Procter & Gamble Processo para fabricação de uréias 1,3-di-substituìdas-4-oxocìclicas
US7086484B2 (en) * 2003-06-09 2006-08-08 Halliburton Energy Services, Inc. Determination of thermal properties of a formation
US9255088B2 (en) 2010-08-11 2016-02-09 The Regents Of The University Of California Premature-termination-codons readthrough compounds
WO2013142346A1 (en) 2012-03-23 2013-09-26 The Regents Of The University Of California Premature-termination-codons readthrough compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3084171A (en) * 1961-10-19 1963-04-02 Abbott Lab 5-nitro-2-furylamidine and alkyl 5-nitro-2-furylimidate

Also Published As

Publication number Publication date
DE2526799A1 (de) 1976-01-02
BE830345A (fr) 1975-12-17
FR2279393B1 (US08124630-20120228-C00102.png) 1980-05-16
NL7502598A (nl) 1975-12-19
GB1443503A (en) 1976-07-21
SE418292B (sv) 1981-05-18
AU7781575A (en) 1976-08-05
ES438652A1 (es) 1977-06-16
JPS5111758A (US08124630-20120228-C00102.png) 1976-01-30
FR2279393A1 (fr) 1976-02-20
SE7506839L (sv) 1975-12-18
ZA75434B (en) 1976-08-25
US3906010A (en) 1975-09-16
CA1019328A (en) 1977-10-18

Similar Documents

Publication Publication Date Title
FR2281819B1 (US08124630-20120228-C00102.png)
FR2276916B1 (US08124630-20120228-C00102.png)
FR2283936B1 (US08124630-20120228-C00102.png)
FR2264769A1 (US08124630-20120228-C00102.png)
FR2279393B1 (US08124630-20120228-C00102.png)
FR2259163B1 (US08124630-20120228-C00102.png)
FR2288719B1 (US08124630-20120228-C00102.png)
FR2262491B1 (US08124630-20120228-C00102.png)
FR2269506A1 (US08124630-20120228-C00102.png)
AU495930B2 (US08124630-20120228-C00102.png)
FR2278108B2 (US08124630-20120228-C00102.png)
JPS50101600U (US08124630-20120228-C00102.png)
BG19768A1 (US08124630-20120228-C00102.png)
BG22114A1 (US08124630-20120228-C00102.png)
BG20440A1 (US08124630-20120228-C00102.png)
BG20446A1 (US08124630-20120228-C00102.png)
BG20451A1 (US08124630-20120228-C00102.png)
BG20462A1 (US08124630-20120228-C00102.png)
BG20638A1 (US08124630-20120228-C00102.png)
CH566410A5 (US08124630-20120228-C00102.png)
BG20883A1 (US08124630-20120228-C00102.png)
BG20950A1 (US08124630-20120228-C00102.png)
BG21129A1 (US08124630-20120228-C00102.png)
BG21307A1 (US08124630-20120228-C00102.png)
BG21351A1 (US08124630-20120228-C00102.png)

Legal Events

Date Code Title Description
PUE Assignment

Owner name: NORWICH EATON PHARMACEUTICALS, INC.

PL Patent ceased